Hybrid-Compounds Against Trypanosomiases.

Area of Science:

• Medicinal Chemistry
• Parasitology
• Drug Discovery

Background:

• Neglected tropical diseases (NTDs), including Chagas disease (CD) and human African trypanosomiasis (HAT), pose significant global health challenges.
• Current pharmacological treatments for these parasitic infections are often limited in efficacy.
• There is a critical need for novel therapeutic agents to combat these debilitating diseases.

Approach:

• This review explores molecular hybridization as a drug design strategy for developing antiparasitic agents.
• It compiles recent studies utilizing hybrid compounds from various chemical classes, such as thiazolidinones, naphthoquinones, and quinolines.
• The focus is on leveraging molecular hybridization to create drug candidates targeting trypanosomiases.

Key Points:

• Molecular hybridization is an effective tool for designing ligands that can modulate multiple targets relevant to complex diseases.
• The review highlights the application of hybrid compounds in developing potential treatments for parasitic diseases.
• Specific chemical classes, including thiazolidinones, naphthoquinones, and quinolines, have been investigated within this strategy.

Conclusions:

• Molecular hybridization presents a potent strategy for the development of novel molecules with trypanocidal activity.
• This approach can aid in designing new drugs to address the unmet medical needs in treating trypanosomiases.
• Further exploration of molecular hybridization is crucial for advancing drug discovery against NTDs.